Key result
Perioperative antihypertensives, particularly beta-blockers, are recommended to reduce CV morbidity and mortality during noncardiac surgery.
Why the study?
How should antihypertensive therapy be managed in patients undergoing noncardiac surgery to reduce perioperative cardiovascular risk?
Population
Hypertensive patients undergoing noncardiac surgery
Design
Review
Authors
Loading...
Supports perioperative beta-blocker recommendations in hypertensives; leaves open optimal regimens pending randomized trials.
How should antihypertensive therapy be managed in patients undergoing noncardiac surgery to reduce perioperative cardiovascular risk?
Hypertensive patients undergoing noncardiac surgery should have blood pressure controlled to <180/110 mm Hg and receive perioperative beta-blocker therapy to reduce cardiovascular risk.
DeQuattro et al. (1997) conducted a review in Hypertension in patients undergoing noncardiac surgery. Antihypertensive therapy (beta-blockers) was evaluated. Perioperative antihypertensive therapy, particularly beta-blockers, is recommended to reduce cardiovascular morbidity and mortality in hypertensive patients undergoing noncardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: